Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dose that can be safely given to see what
effect it may have on your cancer and to determine how the drug is distributed in the body.